Evidence map›Paper›PMID 34351504›Full record

Trial reportClinical oral investigations2022

Combination of two desensitizing protocols to control dentin hypersensitivity in non-carious lesions: a randomized, double-blind clinical trial.

Antonia Patricia Oliveira Barros, Cristiane de Melo Alencar, Alexandra de Melo Pingarilho Carneiro, Danielle da Silva Pompeu, Gabriela Monteiro Barbosa, Jesuína Lamartine Nogueira Araújo, Cecy Martins Silva

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06417580 (Effect of Experimental Pregabalin Gel in Controlling Cervical Dentin Hypersensitivity), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06417580 phase2unknown statusnot on this mapstarted 2024, after this paper: background citation

Effect of Experimental Pregabalin Gel in Controlling Cervical Dentin Hypersensitivity: a Randomized, Double-blind, Controlled Clinical Study

TypeinterventionalSponsorJesuína Lamartine Nogueira AraújoRan2024 to 2024Enrolled18ConditionsDentin SensitivityArmsPlacebo Treatment, Nitrate Potassium Treatment, Pregabalin Treatment
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Applications of Bioactive Strontium Compounds in Dentistry.Journal of functional biomaterials · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Antonia Patricia Oliveira BarrosSchool of Dentistry, Federal University of Pará, Belém, Pará, Brazil.
Cristiane de Melo AlencarAraraquara School of Dentistry, Paulista State University, Araraquara, SP, Brazil.
Alexandra de Melo Pingarilho CarneiroDental Materials Laboratory of the Postgraduate Program in Dentistry, Federal University of Pará, Belém, Pará, Brazil.
Danielle da Silva PompeuSchool of Dentistry, Federal University of Pará, Belém, Pará, Brazil.
Gabriela Monteiro BarbosaDental Materials Laboratory of the Postgraduate Program in Dentistry, Federal University of Pará, Belém, Pará, Brazil.
Jesuína Lamartine Nogueira AraújoDental Materials Laboratory of the Postgraduate Program in Dentistry, Federal University of Pará, Belém, Pará, Brazil.
Cecy Martins SilvaDental Materials Laboratory of the Postgraduate Program in Dentistry, Federal University of Pará, Belém, Pará, Brazil. cecymsilva@gmail.com.ORCID http://orcid.org/0000-0002-7870-8848
Universidade Federal do Pará · BRUniversidade Paulista · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study evaluated the effect of photobiomodulation (PBM) combined with 8% strontium acetate (SA8%) in the treatment of dentin hypersensitivity (DH) in non-carious lesions and analyzed the risk factors with the patient's quality of life.

methodsEighty teeth with DH were randomly allocated into four treatment groups (n = 20): G1, PBM imitation + toothpaste with no active ingredient; G2, PBM imitation + toothpaste with SA8%; G3, PBM + toothpaste without the active ingredient; and G4, PBM + toothpaste with SA8%. Participants were provided with a questionnaire on the experience of dentin hypersensitivity (QEDH) to assess the impact of desensitizing treatment on health-related quality of life (HRQL). Friedman and Kruskal-Wallis tests were used for intra- and intergroup comparisons, and Wilcoxon and Mann-Whitney tests were used to analyze HRQL. All analyses used significance levels of 5%.

resultsIntergroup comparisons revealed a significant difference (p < 0.05); G4 had the best response in terms of HD reduction in G4 compared to the other groups on the 7th day of assessment (T3). Only G4 showed a statistically significant difference (p < 0.05) in the reduction of EDH for intragroup analysis.

conclusionThe combination of therapies was more effective in reducing DH than the isolated use of these strategies. CLINICAL RELEVANCE: The combination of therapies is effective in the treatment of DH.

Indexed as

Dentin Desensitizing AgentsDentin SensitivityDouble-Blind MethodFluoridesHumansQuality of LifeToothpastesTreatment OutcomeDentin Desensitizing AgentsFluoridesToothpastesDentin hypersensitivityQuality of lifeRisk factorsTherapy

Identifiers

PMID34351504
OpenAlexW3187185144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.